| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Beone Medicines AG's insiders have reduced their positions by a net 31,028 shares worth roughly $11.3M. In the past 30 days, 0 insiders bought and 1 sold.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 397.9K | $141.25M | - | |
| Dir | 161.6K | $57.35M | - | |
| Other | 99.6K | $35.37M | - | |
| Dir | 83.7K | $29.72M | - | |
| Dir | 73.2K | $25.97M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 2, 2021 | Jane Huang81 | CMO, Hematology | Sell | 1,087 | $318.88 | $346,620.90 | -100% | +5.7% | -49.9% | |
| Aug 5, 2021 | John Oyler58 | Chief Executive Officer | Sell | 125,309 | $132.34 | $16,583,633.80 | -100% | +11.3% | -42.1% | |
| Aug 3, 2021 | John Oyler58 | Chief Executive Officer | Sell | 83,359 | $182.37 | $15,202,048.13 | -100% | +4.7% | -50.3% | |
| Jul 22, 2021 | John Oyler58 | Chief Executive Officer | Sell | 69,216 | $71.82 | $4,971,360.27 | -100% | +15.8% | -43.9% | |
| Jul 21, 2021 | John Oyler58 | Chief Executive Officer | Sell | 70,855 | $152.13 | $10,778,876.79 | -100% | +22.6% | -38.5% | |
| Jul 15, 2021 | Jane Huang81 | CMO, Hematology | Sale+OE | 21,000 | $332.42 | $6,980,770.98 | - | +7.4% | -46.6% | |
| Jul 8, 2021 | John Oyler58 | Chief Executive Officer | Sell | 17,281 | $318.67 | $5,506,959.78 | -100% | +5.9% | -41.0% | |
| Jul 7, 2021 | John Oyler58 | Chief Executive Officer | Sell | 123,821 | $117.22 | $14,514,636.75 | -99.8% | +10.2% | -39.3% | |
| Jul 6, 2021 | Xiaobin Wu52 | President, COO & Gm China | Sell | 10,180 | $325.53 | $3,313,926.81 | -100% | +9.3% | -44.1% | |
| Jul 1, 2021 | Xiaodong Wang58 | Director, Chair, Scientific Advisory Brd | Sell | 4,848 | $348.15 | $1,687,852.35 | -100% | +3.4% | -52.3% |